Dopamine D-1, dopamine D-2, and prolactin receptor messenger ribonucleic acid expression by the polymerase chain reaction in human meningiomas

被引:18
作者
Carroll, RS
Schrell, UMH
Zhang, JP
Dashner, K
Nomikos, P
Fahlbusch, R
Black, PM
机构
[1] BRIGHAM & WOMENS HOSP,BRAIN TUMOR CTR,BOSTON,MA 02115
[2] CHILDRENS HOSP,BOSTON,MA
[3] DANA FARBER CANC INST,BOSTON,MA 02115
[4] HARVARD UNIV,SCH MED,DEPT SURG,BOSTON,MA 02115
[5] UNIV ERLANGEN NURNBERG,DEPT NEUROSURG,W-8520 ERLANGEN,GERMANY
关键词
dopamine receptors; meningiomas; polymerase chain reaction; prolactin receptors;
D O I
10.1097/00006123-199602000-00027
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
PREVIOUS STUDIES HAVE suggested the presence of high-affinity dopamine D-1 receptors and prolactin receptors in human cerebral meningiomas. In this study, using the polymerase chain reaction, we report the presence of the messenger ribonucleic acid (mRNA) for the dopamine D-1 and D-2 receptors and the prolactin receptor in meningioma tissue specimens and cell cultures derived from meningioma tissue. Dopamine D-1 receptor mRNA was present in a majority of female tissue specimens and in all male tissue specimens. D-2 receptor mRNA was detected in all specimens examined. Prolactin receptor mRNA was present in a little more than half of the female and male meningioma tumor specimens. The polymerase chain reaction products were directly sequenced to confirm the identity of these receptors in meningiomas and cell cultures. Ligand binding studies confirmed the presence of the dopamine D-1 receptor in meningioma tissue specimens. In contrast, receptor studies with the dopamine D-2 ligand [I-125]4-iodospiperone failed to detect D-2 binding in meningioma membrane preparations. These results suggest the existence of active dopamine D-2 receptors in cerebral meningiomas.
引用
收藏
页码:367 / 374
页数:8
相关论文
共 40 条
  • [1] ABRAMSON SN, 1987, MOL PHARMACOL, V31, P103
  • [2] HORMONAL DEPENDENCY OF CEREBRAL MENINGIOMAS .2. INVITRO EFFECT OF STEROIDS, BROMOCRIPTINE, AND EPIDERMAL GROWTH-FACTOR ON GROWTH OF MENINGIOMAS
    ADAMS, EF
    SCHRELL, UMH
    FAHLBUSCH, R
    THIERAUF, P
    [J]. JOURNAL OF NEUROSURGERY, 1990, 73 (05) : 750 - 755
  • [3] GALACTORRHEA - SUCCESSFUL TREATMENT WITH REDUCTION OF PLASMA PROLACTIN LEVELS BY BROM-ERGOCRYPTINE
    BESSER, GM
    MCNEILLY, AS
    EDWARDS, CRW
    PARKE, L
    FORSYTH, IA
    [J]. BRITISH MEDICAL JOURNAL, 1972, 3 (5828) : 669 - &
  • [4] THE RELAPSING COURSE OF CERTAIN MENINGIOMAS IN RELATION TO PREGNANCY AND MENSTRUATION
    BICKERSTAFF, ER
    SMALL, JM
    GUEST, IA
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1958, 21 (02) : 89 - 91
  • [5] IDENTIFICATION OF A CDNA-ENCODING A LONG FORM OF PROLACTIN RECEPTOR IN HUMAN HEPATOMA AND BREAST-CANCER CELLS
    BOUTIN, JM
    EDERY, M
    SHIROTA, M
    JOLICOEUR, C
    LESUEUR, L
    ALI, S
    GOULD, D
    DJIANE, J
    KELLY, PA
    [J]. MOLECULAR ENDOCRINOLOGY, 1989, 3 (09) : 1455 - 1461
  • [6] PROLACTIN IS A TUMOR PROMOTER IN RAT-LIVER
    BUCKLEY, AR
    PUTNAM, CW
    RUSSELL, DH
    [J]. LIFE SCIENCES, 1985, 37 (26) : 2569 - 2575
  • [7] BURGER PC, 1991, SURGICAL PATHOLOGY N, P67
  • [8] CARROLL RS, 1993, CANCER RES, V53, P1312
  • [9] ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE
    CHIRGWIN, JM
    PRZYBYLA, AE
    MACDONALD, RJ
    RUTTER, WJ
    [J]. BIOCHEMISTRY, 1979, 18 (24) : 5294 - 5299
  • [10] MOLECULAR-CLONING AND EXPRESSION OF THE GENE FOR A HUMAN D1 DOPAMINE RECEPTOR
    DEARRY, A
    GINGRICH, JA
    FALARDEAU, P
    FREMEAU, RT
    BATES, MD
    CARON, MG
    [J]. NATURE, 1990, 347 (6288) : 72 - 76